Cha Hospital will hold a patient-friendly in vitro baby procedure international fertility symposium on the 25th
Oct 21, 2024
Cha Hospital of Cha Medical University will hold the '2nd Patient-Friendly In vitro Baby Treatment (IVF) International Infertility Symposium' at Pangyo Cha Bio Complex from 12:50 p.m. on the 25th. Through symposiums, we seek direct solutions to the low birth rate problem that is a problem worldwide.
The symposium will be held jointly by Cha Medical Center, Cha Medical University, and the Asia-Pacific Life Medicine Research Foundation, which has global infertility and reproductive medicine medical staff and researchers, and will be attended by world-renowned infertility and reproductive medicine researchers.
Professor Fabrizio Horta of the University of New South Wales in Australia, Kathleen Miller, chief scientific officer of Innovation Fertility in the United States, Alison Campbell, chief scientific officer of UK Care Infertility Group, Masahide Shiotani, director of Hana Busa Women's Clinic in Japan, Tetsunori Mukaida, director of Hiroshima HART Clinic in Japan, and more than 200 domestic and foreign infertility researchers will gather to share the latest infertility treatment technology combined with artificial intelligence and discuss new treatments.
The symposium, which will be held in two parts, will share various clinical experiences with topics that have recently attracted attention among infertile medical scientists around the world, including the operation of the world's best laboratory, ways to create a practical research environment, and the promotion of IVF (In Vitro Fertilization) pregnancy rates incorporating artificial intelligence (AI).
In the first part, ▲ Are non-invasive metabolic angiography and artificial intelligence new technologies for assisted reproductive technology (ART)? (Professor Fabrizio Horta, University of New South Wales, Australia) ▲ Artificial intelligence technology in infertility (CEO Lee Hye-joon of Kai Health) will be presented.
In the second part, ▲ Is the comparison between artificial intelligence (AI) and humans a correct approach? (Castlin Miller, Chief Scientific Officer of Innovation Properties, U.S.) ▲ Methods of Collecting Stallion in Patients with Extremely Resistant Treatment (Masahide Shiotani, Director of Hana-Busa Women's Clinic in Japan) ▲ Maximizing laboratory performance of ICSI and assisted reproductive techniques (ART) through Timelapse monitoring and PGT-A programs (Tetsunori Mukaida, Director of Hiroshima HART Clinic in Japan) ▲ Standardization within the network of infertility clinics (Alison.
Cha Kwang-ryul Cha Hospital and Bio"The most direct and immediate solution to the problem of low birth is solving the problem of infertility in a situation where the problem of low birth is serious worldwide," said Group Global Research Center Director "The symposium will discuss various ways to increase the success rate of pregnancy through combination with artificial intelligence and quality control in the fertility laboratory." We hope that it will also be a great inspiration for each field, such as government and administrators dealing with low-birthrate issues around the world."
Director of Reproductive Medicine Lee Kyung-ah said, `As a leader in infertility and reproductive medicine, Cha Hospital holds an annual international symposium and invites leading domestic and foreign medical staff and researchers to share the latest knowledge and seek customized treatment for patients""Using the network of 91 medical institutions in seven countries, we will continue to use innovation and development in the field of infertility and reproductive medicine through active academic exchanges."."
Inquiries about this symposium can be made to the General Headquarters of Reproductive Medicine at Cha Medical Center.
The symposium will be held jointly by Cha Medical Center, Cha Medical University, and the Asia-Pacific Life Medicine Research Foundation, which has global infertility and reproductive medicine medical staff and researchers, and will be attended by world-renowned infertility and reproductive medicine researchers.
Professor Fabrizio Horta of the University of New South Wales in Australia, Kathleen Miller, chief scientific officer of Innovation Fertility in the United States, Alison Campbell, chief scientific officer of UK Care Infertility Group, Masahide Shiotani, director of Hana Busa Women's Clinic in Japan, Tetsunori Mukaida, director of Hiroshima HART Clinic in Japan, and more than 200 domestic and foreign infertility researchers will gather to share the latest infertility treatment technology combined with artificial intelligence and discuss new treatments.
The symposium, which will be held in two parts, will share various clinical experiences with topics that have recently attracted attention among infertile medical scientists around the world, including the operation of the world's best laboratory, ways to create a practical research environment, and the promotion of IVF (In Vitro Fertilization) pregnancy rates incorporating artificial intelligence (AI).
In the first part, ▲ Are non-invasive metabolic angiography and artificial intelligence new technologies for assisted reproductive technology (ART)? (Professor Fabrizio Horta, University of New South Wales, Australia) ▲ Artificial intelligence technology in infertility (CEO Lee Hye-joon of Kai Health) will be presented.
In the second part, ▲ Is the comparison between artificial intelligence (AI) and humans a correct approach? (Castlin Miller, Chief Scientific Officer of Innovation Properties, U.S.) ▲ Methods of Collecting Stallion in Patients with Extremely Resistant Treatment (Masahide Shiotani, Director of Hana-Busa Women's Clinic in Japan) ▲ Maximizing laboratory performance of ICSI and assisted reproductive techniques (ART) through Timelapse monitoring and PGT-A programs (Tetsunori Mukaida, Director of Hiroshima HART Clinic in Japan) ▲ Standardization within the network of infertility clinics (Alison.
Cha Kwang-ryul Cha Hospital and Bio"The most direct and immediate solution to the problem of low birth is solving the problem of infertility in a situation where the problem of low birth is serious worldwide," said Group Global Research Center Director "The symposium will discuss various ways to increase the success rate of pregnancy through combination with artificial intelligence and quality control in the fertility laboratory." We hope that it will also be a great inspiration for each field, such as government and administrators dealing with low-birthrate issues around the world."
Director of Reproductive Medicine Lee Kyung-ah said, `As a leader in infertility and reproductive medicine, Cha Hospital holds an annual international symposium and invites leading domestic and foreign medical staff and researchers to share the latest knowledge and seek customized treatment for patients""Using the network of 91 medical institutions in seven countries, we will continue to use innovation and development in the field of infertility and reproductive medicine through active academic exchanges."."
Inquiries about this symposium can be made to the General Headquarters of Reproductive Medicine at Cha Medical Center.
|
bellho@sportschosun.com
